Currently predicting for Thu, 4 Jun 2026

MESO Prediction Chart

MESO Predictions History

Latest community submissions for MESO.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 12, 2026 $20.66 -1.45% $18.67 V 89.37% 1
Jan 12, 2026 $20.77 -0.91% $18.67 V 88.75% 1
Jan 12, 2026 Bullish $18.67 X 0
Sep 22, 2025 $16.73 -1.65% $16.85 V 99.28% 4
Sep 22, 2025 $16.83 -1.03% $16.85 V 99.91% 10
Sep 22, 2025 $19.75 +16.11% $16.85 X 82.79% 0
Sep 12, 2025 $15.11 -1.70% $14.82 V 98.05% 1
Sep 12, 2025 $15.21 -1.06% $14.82 V 97.39% 1
Sep 12, 2025 Bullish $14.82 X 0
Jan 16, 2025 $17.65 +3.24% $16.67 X 94.10% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for MESO with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT MESOBLAST LTD
Mesoblast
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchyma...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE